WallStreetZenWallStreetZen

NASDAQ: BVS
Bioventus Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Bioventus earnings were $22.7M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest BVS earnings report on Dec 31, 2025 announced Q4 2025 earnings of $14.8M, up 367.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BVS reported annual earnings of $22.7M, with -162.9% growth.

BVS past earnings growth

How has BVS's earnings growth performed historically?

Company
N/A
Industry
22.81%
Market
87.94%
BVS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BVS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

BVS earnings history

Current Revenue
$568.1M
Current Earnings
$22.7M
Current Profit Margin
4%

BVS Return on Equity

Current Company
13.8%
Current Industry
9.3%
Current Market
29.3%
BVS's Return on Equity (13.8%)... subscribe to Premium to read more.
High Return on Equity Performance

BVS Return on Assets

Current Company
3.3%
Current Industry
5.7%
BVS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BVS announces earnings.

BVS Return on Capital Employed

Current Company
9.11%
Current Industry
9.8%
BVS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BVS vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BVS$94.66M$22.73M-17.51%$0.34
CBLL-$50.28M-$53.41MN/A-$1.46
IART-$326.40M-$516.47MN/A-$6.74
AVNS-$19.50M-$72.90MN/A-$1.57
INMD$111.03M$93.83M+6.87%$1.45
View Top Medical Device Stocks

Bioventus Earnings Reports & History FAQ

What were Bioventus's earnings last quarter?

On BVS's earnings call on Invalid Date, Bioventus (NASDAQ: BVS) reported Q4 2025 earnings per share (EPS) of $0.22, up Infinity% year over year. Total BVS earnings for the quarter were $14.76 million. In the same quarter last year, Bioventus's earnings per share (EPS) was $0.00.

If you're new to stock investing, here's how to buy Bioventus stock.

Is Bioventus profitable or losing money?

As of the last Bioventus earnings report, Bioventus is currently profitable. Bioventus's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $22.73 million, a 162.93% decrease year over year.

What was BVS's earnings growth in the past year?

As of Bioventus's earnings date in Invalid Date, Bioventus's earnings has grown year over year. BVS earnings in the past year totalled $22.73 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.